Skip to content

High Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy

High Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02156141
Acronym
HIT in Kennedy
Enrollment
10
Registered
2014-06-05
Start date
2014-06-30
Completion date
2016-06-01
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal and Bulbar Muscular Atrophy, Healthy Subjects

Keywords

Kennedy's disease, Spinal and bulbar muscular atrophy, High Intensity Training, High Intensity Interval Training, HIT, HIIT, Training, Exercise, 10-20-30

Brief summary

We want investigate if high intensity training can increase daily functionality without causing muscle damage in patients Spinal and Bulbar Muscular Atrophy . We want to study if there is a difference in effect with supervised and unsupervised training. Furthermore we want to study if a supervised training program will motivate participants to continue training by the end of the program.

Interventions

OTHERSupervised high intensity training

8 weeks of supervised training

8 weeks of optional training on cycle ergometer. No program needs to be followed. Participant decides whether they want to keep training or not.

8 weeks with no training.

OTHERUnsupervised High intensity training

8 weeks of unsupervised high intensity training.

Sponsors

Karen Brorup Heje Pedersen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed with Spinal and bulbar muscular atrophy or * Healthy control subjects matched individually with participating patients on age, sex, BMI and activity level.

Exclusion criteria

* More than 1 hour of fitness weekly before inclusion * Other disease possibly confounding the results * Pregnancy or breastfeeding * Participations in other scientific studies wich could influence on the results during the last 30 days before inclusion. * Physical and/or mental conditions preventing participating in the study protocol.

Design outcomes

Primary

MeasureTime frameDescription
Incremental testBaseline, week 6, week 11, week 18Primary outcome is changes from baseline in maximal oxygen consumption and maximal workload after a 8 week supervised training program followed by a 8 week non-supervised optional training period. during and after 8 weeks of High Intensity Training on a cycle ergometer. The outcome is measured by an incremental test on a cycle ergometer.

Secondary

MeasureTime frameDescription
Functional testBaseline, week 6, week 11, week 18.Changes from baseline to end of training in muscle strength measured by handhold dynamometry, in 6 minute walk-test and in 5 time sit-to-stand test is secondary outcome.
Self-rated muscle fatigue, muscle pain and activity levelEvery day in week 1-11Self-rated muscle fatigue, muscle pain (VAS) and activity level is noted every day in diary in the two run-in weeks (baseline data) and thereafter every day in the 8 weeks training program. Changes from baseline is a secondary outcome.
Serum concentrations of Creatine Kinase (CK)Baseline, Week 3,4,5,6,7,8,9,10,11, week 18.Serum concentrations of Creatine Kinase (CK) as a measurement of muscle damage. Blood samples are taken at every test day wich is the same for patient group 1 and healthy controls. In patient group 2 blood samples are taken at baseline, week 6, week 11 and week 18-
Activity levelBaseline, week 10 and week 18.Activity levels are measured by using a pedometer for a week at baseline, week 10 and week 18. Changes from baseline is a secondary outcome.

Other

MeasureTime frameDescription
Serum IGF-1Baseline, week 11, week 18.Changes in serum IGF-1 from baseline to week 11 and 18.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026